UBS Group’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-42,787
| Closed | -$30.7K | – | 9039 |
|
|
2024
Q1 | $30.7K | Sell |
42,787
-233
| -0.5% | -$167 | ﹤0.01% | 5563 |
|
|
2023
Q4 | $36.6K | Buy |
43,020
+33,656
| +359% | +$28.6K | ﹤0.01% | 5522 |
|
|
2023
Q3 | $12.8K | Sell |
9,364
-15,607
| -63% | -$21.4K | ﹤0.01% | 5873 |
|
|
2023
Q2 | $62.9K | Buy |
24,971
+22,304
| +836% | +$56.2K | ﹤0.01% | 5290 |
|
|
2023
Q1 | $6.05K | Buy |
2,667
+1,392
| +109% | +$3.16K | ﹤0.01% | 6868 |
|
|
2022
Q4 | $1.79K | Sell |
1,275
-4,581
| -78% | -$6.41K | ﹤0.01% | 8593 |
|
|
2022
Q3 | $12K | Buy |
+5,856
| New | +$12K | ﹤0.01% | 7109 |
|
|
2022
Q1 | – | Sell |
-2,566
| Closed | -$14K | – | 9811 |
|
|
2021
Q4 | $14K | Buy |
+2,566
| New | +$14K | ﹤0.01% | 7250 |
|